Rozerem DTC Ad Suggests Insomnia Drug Is Indicated In Children – FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency issues an "untitled" letter to Takeda citing the 10-second TV spot.
You may also be interested in...
FDAAA’s First Advertising Victim Is MedImmune’s FluMist
“Reminder” newspaper ad actually makes claims and lacks toll-free number for reporting side effects, FDA says.
FDAAA’s First Advertising Victim Is MedImmune’s FluMist
“Reminder” newspaper ad actually makes claims and lacks toll-free number for reporting side effects, FDA says.
Leave It To Beaver: Rozerem DTC Campaign Boosts New Rx Share
Takeda sleep aid’s new Rx share has grown more than 50% since campaign began.